Can two advanced heart maps guide a more precise fix for dangerous arrhythmias?
NCT ID NCT07746336
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This trial tests whether combining two advanced heart-mapping technologies can make ablation for ventricular tachycardia (VT) more accurate and effective. The approach merges a non-invasive 3D electrical map of the heart with detailed scar imaging from an MRI, aiming to better target the abnormal tissue causing the arrhythmia. The study enrolls adults with structural heart disease who are scheduled for VT ablation, and it will track whether the combined mapping reduces VT recurrence and improves procedural success.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A combined mapping workflow using two CE-marked devices: ADAS 3D, which analyzes cardiac MRI to characterize scar tissue, and ACORYS, which performs non-invasive electrocardiographic mapping to guide and verify ventricular tachycardia ablation.
- What this could lead to
- If successful, this approach could make ventricular tachycardia ablation more precise, potentially reducing the chance of the arrhythmia returning and improving long-term outcomes for people with structural heart disease.
- What could go wrong
- This is a relatively small, early-stage feasibility study, so results may not apply broadly. The added complexity of combining two mapping systems could also introduce technical challenges or longer procedure times.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMIC BURDEN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clinic, University of Barcelona
Barcelona, 08036, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a short course of steroids calm a dangerous heart rhythm?
- CT scan roadmap may improve heart ablation success
- 4,000 heart patients to be tracked after ablation procedure
- Smart patches could save hearts: hospital trial tests continuous monitoring
- Heart rhythm showdown: ablation may beat defibrillator for some patients
- Heart drug study halted early: what we know